Patent · US Active

Use of phthalide derivatives for the treatment of type 2 diabetes mellitus

US8242168B2 · kind B2 · utility

0Cited by

1References

9Claims

0Family size

Assignee

DSM IP ASSETS B.V. · NL

Inventors

Daniel D'Orazio · Solothurn, CH
Antoine De Saizieu · Mulhouse, FR
Goede Schueler · Weil am Rhein, DE
Daniel Raederstorff · Flaxlanden, FR
Sandra Teixeira · Brookline, US
Ying Wang Schmidt · Basel, CH
Peter Weber · Kandern, DE
Swen Wolfram · Waldshut-Tiengen, DE

Key dates

Filing date	Mar 27, 2009
Grant date	Aug 14, 2012
Priority date	—
Expiry date	Jul 13, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P3/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to the use of a compound as effective agent for the prevention or treatment of diabetes mellitus in a mammal. Said compounds being selected from the group of phthalide derivatives and exhibit excellent blood glucose lowering effects and thus are effective agents in the prevention or treatment of diabetes mellitus in mammals.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.